Lantheus Holdings (LNTH) Income from Continuing Operations (2014 - 2026)
Lantheus Holdings' (LNTH) quarterly Income from Continuing Operations came in at $75.0 million in Q2 2026, down 4.73% year-over-year from $78.8 million in Q2 2025, and down 36.64% quarter-over-quarter from $118.4 million in Q1 2026.
Analysis
Lantheus Holdings (LNTH) Income from Continuing Operations (2014 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Income from Continuing Operations for 13 consecutive years, with $75.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Income from Continuing Operations fell 4.73% year-over-year to $75.0 million in Q2 2026; TTM through Jun 2026 was $281.8 million, a 16.93% increase from a year earlier, with the FY2025 full-year figure at $240.0 million, down 15.01% from the prior year.
- Income from Continuing Operations was $75.0 million for Q2 2026 at Lantheus Holdings, down from $118.4 million in the prior quarter.
- Over five years, Income from Continuing Operations peaked at $132.0 million in Q3 2023 and troughed at -$119.2 million in Q4 2022.
- A 5-year average of $56.4 million and a median of $61.7 million in 2022 frame the typical range for Income from Continuing Operations.
- Across the five-year window, Income from Continuing Operations sank 196.37% in 2022 and soared 4769.26% in 2024, its largest moves.
- Over 5 years, Income from Continuing Operations stood at -$119.2 million in 2022, then soared by 140.06% to $47.7 million in 2023, then slumped by 187.58% to -$41.8 million in 2024, then jumped by 244.82% to $60.6 million in 2025, then grew by 23.89% to $75.0 million in 2026.
- The last three Income from Continuing Operations figures came in at $75.0 million (Q2 2026), $118.4 million (Q1 2026), and $60.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 31.10 Bn | 29.22 Bn | 2.18 Bn | 574.00 Mn |
| 2 | Lantheus Holdings | 6.59 Bn | 6.00 Bn | 241.86 Mn | 75.03 Mn |
| 3 | Heartflow | 4.24 Bn | 3.87 Bn | 53.19 Mn | -15.74 Mn |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn | -10.50 Mn |
| 5 | Butterfly Network | 1.75 Bn | 1.62 Bn | 23.29 Mn | -12.91 Mn |
| 6 | QuidelOrtho | 954.15 Mn | 830.75 Mn | - | - |
| 7 | Ceribell | 944.88 Mn | 815.62 Mn | 25.94 Mn | -19.27 Mn |
| 8 | Anbio Biotechnology | 941.05 Mn | 929.15 Mn | - | - |
| 9 | Varex Imaging | 780.16 Mn | 694.86 Mn | 76.70 Mn | 15.90 Mn |
| 10 | Prenetics Global | 357.49 Mn | 298.35 Mn | 30.20 Mn | -9.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 75.03 Mn |
| Mar 31, 2026 | 118.42 Mn |
| Dec 31, 2025 | 60.56 Mn |
| Sep 30, 2025 | 27.77 Mn |
| Jun 30, 2025 | 78.76 Mn |
| Mar 31, 2025 | 72.95 Mn |
| Dec 31, 2024 | -41.82 Mn |
| Sep 30, 2024 | 131.09 Mn |
| Jun 30, 2024 | 62.07 Mn |
| Mar 31, 2024 | 131.07 Mn |
| Dec 31, 2023 | 47.75 Mn |
| Sep 30, 2023 | 131.96 Mn |
| Jun 30, 2023 | 94.13 Mn |
| Mar 31, 2023 | -2.81 Mn |
| Dec 31, 2022 | -119.19 Mn |
| Sep 30, 2022 | 61.23 Mn |
| Jun 30, 2022 | 43.06 Mn |
| Mar 31, 2022 | 42.96 Mn |
| Dec 31, 2021 | -40.22 Mn |
| Sep 30, 2021 | -13.42 Mn |